Aurora Cannabis increases its stake in CanniMed Therapeutics to 2.3%

VANCOUVER — Aurora Cannabis Inc.  says it has purchased 116,000 common shares of CanniMed Therapeutics Inc. (TSX:CMED), increasing its equity stake in the company to about 2.3 per cent.
Last Friday, Vancouver-headquartered Aurora announced it had purchased 450,000 common shares of CanniMed, equivalent to about 1.8 per cent of the company.
Aurora has said it’s allowed to buy up to about five per cent of the Saskatoon-headquartered CanniMed’s stock on the open market. This i